NCT00631618
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasms, +10 more
- Locations
-
- California Pacific Medical Center San Francisco, California, United States
Clinical trial condition
Metastatic Melanoma
Explore clinical trials studying Metastatic Melanoma. Study availability and eligibility vary by location and protocol.
228 public trials
41 recruiting studies
Metastatic Melanoma trial results
NCT00672542
- Conditions
- Absence of CNS Metastases, Melanoma, Metastatic Melanoma, +11 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
NCT00597038
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasms, +10 more
- Locations
-
- Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco San Francisco, California, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT00395070
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasm Metastasis, +14 more
- Locations
-
- Location #40 Tucson, Arizona, United States
- Location #9 Little Rock, Arkansas, United States
- Location #1 Bakersfield, California, United States
- Location #24 San Diego, California, United States
Completed
Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma
NCT00203879
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasms, +10 more
- Locations
-
- The University of Chicago Chicago, Illinois, United States
NCT01743157
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasms, +10 more
- Locations
-
- San Francisco Oncology Associates San Francisco, California, United States
NCT01011530
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasms, +10 more
- Locations
-
- The Angeles Clinic and Research Institute Santa Monica, California, United States
Completed
Melanoma Biomarker Study
NCT00348088
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasm Metastasis, +14 more
- Locations
-
- Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
Completed
Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer
NCT00328861
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +20 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00314106
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasms, +10 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States